The present invention provides a pharmaceutical composition which can be used for the modification of scalp or skin, the promotion of the healing of wounds or the modification of hair, and contains a secretion product from an adipose-derived stem cell as an active ingredient, wherein the secretion product is administered to scalp or skin in an amount of 0.3 to 0.6 μg in terms of protein content per a site on the scalp or skin.